Constance Benson

Title(s)Recall Hcomp, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    The Ohio State University, Columbus, OHMD06/1978Medicine
    Rush University Medical Center, Chicago, IL06/1981Internal Medicine
    Rush University Medical Center, Chicago, IL06/1986Infectious Diseases

    Collapse Overview 
    Collapse Overview
    Constance A. Benson, M.D. is a Professor of Medicine and Global Public Health, Senior Attending Physician, and the Vice Chair for Education and ID Training Program Director for the Division of Infectious Diseases and Global Public Health at University of California, San Diego. She is also the Director of the UCSD Antiviral Research Unit (AVRC), the Principal Investigator (PI) of the UCSD CD4 Collaborative HIV Clinical Trials Unit (CTU) and the Clinical Research Site (CRS) Leader for the UCSD AVRC HIV Clinical Research Site. Dr. Benson received her M.D. degree, Cum Laude from The Ohio State University College of Medicine in 1978, completed her residency in Internal Medicine and a fellowship in Infectious Diseases at Rush University Medical College in Chicago in 1986 after serving three years on active duty in the U.S. Navy as an internist. She was recruited to the faculty of Rush University in the Division of Infectious Diseases in 1986; to the Division of Infectious Diseases at the University of Colorado at Denver in 1997; and to the Division of Infectious Diseases at UCSD in 2005.

    Dr. Benson is an internationally-recognized researcher and clinician working in the fields of HIV and TB clinical and translational investigation since 1984. From 1995 to 2003, Dr. Benson served as the Vice Chair and led the Scientific Agenda Steering Committee, and from 2003 to 2010 served as the Principal Investigator and Chair of the Executive Committee of the NIH/NIAID AIDS Clinical Trials Group (ACTG) Network. The ACTG Network, originally established in 1987, is a multicenter, multinational, therapeutic clinical and translational investigation network with research sites in 13 countries. During her 15 years in the leadership of the ACTG network, and under her scientific and administrative direction, the ACTG expanded its HIV therapeutic research activities to establish international clinical research sites in countries most affected by the HIV/AIDS epidemic, including South Africa, Uganda, Zambia, Botswana, Malawi, Zimbabwe, Tanzania, Kenya, Haiti, Brazil, Peru, India, and Thailand. She oversaw the establishment, training and development of virology, immunology, and pharmacology research laboratories in the US and at international sites, a pharmacogenomics research effort and DNA specimen repository in both the US and internationally for use in HIV-related genomics research, and developed site laboratory capacity to conduct sophisticated diagnostic testing for HIV, tuberculosis, fungal infections and other infectious complications of HIV/AIDS to support ACTG Network trials. She further led the expansion of the ACTG Network activities to include investigational interventions to treat hepatitis B and C and tuberculosis in both mono- and co-infected individuals as part of the network’s scientific agenda. Currently, as the PI of the UCSD CD4 Collaborative CTU and Director of the UCSD Antiviral Research Center, she manages an extensive portfolio of clinical and translational research projects, grants, and contracts, and oversees the conduct of multiple national and international multicenter clinical trials in the fields of HIV/AIDS, viral hepatitis, influenza, tuberculosis and other HIV-related opportunistic complications of global health impact. Her own major areas of research interest include Mycobacterium tuberculosis and other non-tuberculous mycobacterial diseases, other HIV-related opportunistic infections, new antiretroviral drug development, and the treatment of HIV infection and its complications in resource-limited international settings. Most recently her research has focused on the treatment and prevention of HIV-associated tuberculosis, and the development of rapid, point-of-care diagnostic assays for resource-limited settings. Dr. Benson also serves as the UCSD co-director for research capacity development for the NIH-sponsored University of Eduardo Mondlane (UEM) Medical Education Partnership Initiative (MEPI) and two D43 training grants led by Dr. Emilia Noormahomed in Maputo, Mozambique and Dr. Robert Schooley at UCSD. Dr. Benson has also served as a member of the NIH Office of AIDS Research Advisory Council (OARAC) from 2000 to 2003 (Chair from 2001 to 2003), numerous NIH ad hoc study sections, on the Scientific Program Committees for the Infectious Disease Society of America (IDSA), the Conference on Retroviruses and Opportunistic Infections (CROI), and the International AIDS Society (IAS), and on the Board of Directors of the International Antiviral Society-USA, the CROI Foundation Board, the Zimbabwe AIDS Treatment Assistance Project Board, and of Christie’s Place (a non-profit organization supporting women and families affected by HIV infection in San Diego). She serves as a reviewer for 12 major medical journals, as Associate Editor for Clinical Infectious Diseases, and lectures frequently both nationally and internationally on topics within her areas of research and clinical expertise. Dr. Benson is a member of the International AIDS Society, the IDSA, the HIV Medicine Association of the IDSA, the International Union against Tuberculosis and Lung Disease, and the American College of Physicians. Her contributions to the field of HIV/AIDS are numerous. To date, she has published more than 225 original manuscripts, invited reviews, and book chapters, mentored more than 50 trainees in their research and clinical training in ID, and maintains active clinical duties as a subspecialist in Infectious Diseases, HIV and Global Health within the UCSD Health System in San Diego.

    Collapse Research 
    Collapse Research Activities and Funding
    A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
    NIH R01MH110057Sep 20, 2015 - Jul 31, 2021
    Role: Principal Investigator
    UCSD Collaborative Clinical Trials Unit
    NIH UM1AI069432Feb 1, 2007 - Nov 30, 2027
    Role: Principal Investigator
    UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
    NIH U01AI069432Feb 1, 2007 - Nov 30, 2013
    Role: Principal Investigator
    AIDS Clinical Trials Group Network
    NIH U01AI068636Jun 29, 2006 - May 31, 2013
    Role: Principal Investigator
    ADULT ACTG CENTRAL GROUP
    NIH U01AI038858Jan 1, 1996 - Dec 31, 2008
    Role: Principal Investigator
    SAN DIEGO AIDS CLINICAL TRIAL UNIT
    NIH U01AI027670Jun 30, 1986 - Dec 31, 2006
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000051Dec 1, 1978 - Mar 31, 2010
    Role: Co-Investigator
    General Clinical Research Center
    NIH M01RR000827Mar 1, 1974 - Nov 30, 2010
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester. Clin Infect Dis. 2024 03 20; 78(3):667-673. Gupta A, Hughes MD, Cruz JL, Avihingsanon A, Mwelase N, Severe P, Omoz-Oarhe A, Masheto G, Moran L, Benson CA, Chaisson RE, Swindells S. PMID: 37768207; PMCID: PMC10954322.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2. Ann Intern Med. 2024 Mar; 177(3):343-352. Paules CI, Wang J, Tomashek KM, Bonnett T, Singh K, Marconi VC, Davey RT, Lye DC, Dodd LE, Yang OO, Benson CA, Deye GA, Doernberg SB, Hynes NA, Grossberg R, Wolfe CR, Nayak SU, Short WR, Voell J, Potter GE, Rapaka RR. PMID: 38408357.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. A Cross Sectional Study on the Bidirectional Interactions Between Leptospirosis and HIV Infection Among Patients from Maputo Central Hospital, Mozambique. Res Rep Trop Med. 2024; 15:1-11. Comia IR, Manuel L, Miambo RD, Carimo AA, Manjate PDF, Maholela AE, Banze LR, Buene TP, Nhancupe N, Sousa IM, Benson CA, Schooley RT, Sacarlal J, Noormahomed EV. PMID: 38371361; PMCID: PMC10871144.
      View in: PubMed   Mentions:
    4. Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy. Open Forum Infect Dis. 2024 Mar; 11(3):ofad694. Gay CL, Bosch RJ, McKhann A, Cha R, Morse GD, Wimbish CL, Campbell DM, Moseley KF, Hendrickx S, Messer M, Benson CA, Overton ET, Paccaly A, Jankovic V, Miller E, Tressler R, Li JZ, Kuritzkes DR, Macatangay BJC, Eron JJ, Hardy WD, A5370 Team . PMID: 38449916; PMCID: PMC10917183.
      View in: PubMed   Mentions: Translation:CTClinical Trials
    5. Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case. Open Forum Infect Dis. 2023 Jun; 10(6):ofad290. Ortega-Villa AM, Hynes NA, Levine CB, Yang K, Wiley Z, Jilg N, Wang J, Whitaker JA, Colombo CJ, Nayak SU, Kim HJ, Iovine NM, Ince D, Cohen SH, Langer AJ, Wortham JM, Atmar RL, El Sahly HM, Jain MK, Mehta AK, Wolfe CR, Gomez CA, Beresnev T, Mularski RA, Paules CI, Kalil AC, Branche AR, Luetkemeyer A, Zingman BS, Voell J, Whitaker M, Harkins MS, Davey RT, Grossberg R, George SL, Tapson V, Short WR, Ghazaryan V, Benson CA, Dodd LE, Sweeney DA, Tomashek KM. PMID: 37383244; PMCID: PMC10296069.
      View in: PubMed   Mentions:
    6. Inclusion, Diversity, Access, and Equity in Infectious Diseases Fellowship Training: Tools for Program Directors. Open Forum Infect Dis. 2023 Jun; 10(6):ofad289. Luther VP, Barsoumian AE, Konold VJL, Vijayan T, Balba G, Benson C, Blackburn B, Cariello P, Perloff S, Razonable R, Acharya K, Azar MM, Bhanot N, Blyth D, Butt S, Casanas B, Chow B, Cleveland K, Cutrell JB, Doshi S, Finkel D, Graber CJ, Hazra A, Hochberg NS, James SH, Kaltsas A, Kodiyanplakkal RPL, Lee M, Marcos L, Mena Lora AJ, Moore CC, Nnedu O, Osorio G, Paras ML, Reece R, Salas NM, Sanasi-Bhola K, Schultz S, Serpa JA, Shnekendorf R, Weisenberg S, Wooten D, Zuckerman RA, Melia M, Chirch LM. PMID: 37397270; PMCID: PMC10313091.
      View in: PubMed   Mentions:
    7. Microbiological assessment reveals that Salmonella, Shigella and Campylobacter infections are widespread in HIV infected and uninfected patients with diarrhea in Mozambique. PLOS Glob Public Health. 2023; 3(5):e0001877. Hlashwayo DF, Noormahomed EV, Bahule L, Benson C, Schooley RT, Sigaúque B, Barrett KE, Bila CG. PMID: 37216329; PMCID: PMC10202286.
      View in: PubMed   Mentions:
    8. Susceptibility antibiotic screening reveals high rates of multidrug resistance of Salmonella, Shigella and Campylobacter in HIV infected and uninfected patients from Mozambique. BMC Infect Dis. 2023 Apr 21; 23(1):255. Hlashwayo DF, Noormahomed EV, Bahule L, Benson CA, Schooley RT, Sigaúque B, Barrett KE, Bila CG. PMID: 37085752; PMCID: PMC10122284.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    9. Supporting the Art: Medication Adherence Patterns in Persons Prescribed Ingestible Sensor-enabled Oral Pre-Exposure Prophylaxis to Prevent Human Immunodeficiency Virus Infection. Clin Infect Dis. 2023 01 06; 76(1):134-143. Browne SH, Vaida F, Umlauf A, Tucker AJ, Blaschke TF, Benson CA. PMID: 36484300; PMCID: PMC10202440.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    10. Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease. Clin Infect Dis. 2023 01 06; 76(1):103-112. Dedrick RM, Smith BE, Cristinziano M, Freeman KG, Jacobs-Sera D, Belessis Y, Whitney Brown A, Cohen KA, Davidson RM, van Duin D, Gainey A, Garcia CB, Robert George CR, Haidar G, Ip W, Iredell J, Khatami A, Little JS, Malmivaara K, McMullan BJ, Michalik DE, Moscatelli A, Nick JA, Tupayachi Ortiz MG, Polenakovik HM, Robinson PD, Skurnik M, Solomon DA, Soothill J, Spencer H, Wark P, Worth A, Schooley RT, Benson CA, Hatfull GF. PMID: 35676823; PMCID: PMC9825826.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    11. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2023 01 03; 329(1):63-84. Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, Lehmann C, Springer SA, Sax PE, Thompson MA, Benson CA, Buchbinder SP, Del Rio C, Eron JJ, Günthard HF, Molina JM, Jacobsen DM, Saag MS. PMID: 36454551.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    12. A systematic review and meta-analysis of the epidemiology of Leptospirosis in HIV uninfected and in people living with HIV from the Southern African Development Community. PLoS Negl Trop Dis. 2022 12; 16(12):e0010823. Comia IR, Miambo RD, Noormahomed EV, Mahoche M, Pondja A, Schooley RT, Benson C, Sacarlal J. PMID: 36508469; PMCID: PMC9744292.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    13. Addressing the Challenges of Vaccine Hesitancy Broadly and Related to COVID-19 Vaccines. Top Antivir Med. 2022 Dec-Jan; 29(5):430-439. Brown MT, Benson CA. PMID: 35191659; PMCID: PMC8862750.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    14. Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial. Ann Intern Med. 2022 12; 175(12):1716-1727. Potter GE, Bonnett T, Rubenstein K, Lindholm DA, Rapaka RR, Doernberg SB, Lye DC, Mularski RA, Hynes NA, Kline S, Paules CI, Wolfe CR, Frank MG, Rouphael NG, Deye GA, Sweeney DA, Colombo RE, Davey RT, Mehta AK, Whitaker JA, Castro JG, Amin AN, Colombo CJ, Levine CB, Jain MK, Maves RC, Marconi VC, Grossberg R, Hozayen S, Burgess TH, Atmar RL, Ganesan A, Gomez CA, Benson CA, Lopez de Castilla D, Ahuja N, George SL, Nayak SU, Cohen SH, Lalani T, Short WR, Erdmann N, Tomashek KM, Tebas P. PMID: 36442063; PMCID: PMC9709721.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing. Antimicrob Agents Chemother. 2022 09 20; 66(9):e0238521. Pham MM, Podany AT, Mwelase N, Supparatpinyo K, Mohapi L, Gupta A, Samaneka W, Omoz-Oarhe A, Langat D, Benson CA, Chaisson RE, Swindells S, Fletcher CV. PMID: 35943252; PMCID: PMC9487628.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    16. Fostering Sustainable Biomedical Research Training in Mozambique: A Spin-Off of the Medical Education Partnership Initiative. Ann Glob Health. 2022; 88(1):65. Noormahomed EV, Noormahomed S, Hlashwayo D, Martins E, Ismail M, Bickler SW, Nachega J, Mahoche M, Barrett KE, Benson CA, Schooley RT. PMID: 35974986; PMCID: PMC9354555.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection. Nat Commun. 2022 05 03; 13(1):2313. Little JS, Dedrick RM, Freeman KG, Cristinziano M, Smith BE, Benson CA, Jhaveri TA, Baden LR, Solomon DA, Hatfull GF. PMID: 35504908; PMCID: PMC9064978.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    18. Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2. Open Forum Infect Dis. 2022 Jul; 9(7):ofac219. Fintzi J, Bonnett T, Tebas P, Marconi VC, Levine CB, El Sahly HM, McLellan SLF, Benson CA, Rostad CA, Ganesan A, Huprikar N, Frank MG, Mularski RA, Atmar RL, Park PK, Short WR, Beigel JH, Mehta AK, Sweeney DA. PMID: 35818363; PMCID: PMC9129131.
      View in: PubMed   Mentions: 1  
    19. Remdesivir for the Prevention of Invasive Mechanical Ventilation or Death in Coronavirus Disease 2019 (COVID-19): A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data. Clin Infect Dis. 2022 04 09; 74(7):1260-1264. Paules CI, Gallagher SK, Rapaka RR, Davey RT, Doernberg SB, Grossberg R, Hynes NA, Ponce PO, Short WR, Voell J, Wang J, Yang OO, Wolfe CR, Lye DC, Dodd LE, Benson CA. PMID: 34379740; PMCID: PMC8436376.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    20. The impact of the COVID-19 pandemic among migrants in shelters in Tijuana, Baja California, Mexico. BMJ Glob Health. 2022 03; 7(3). Bojorquez-Chapela I, Strathdee SA, Garfein RS, Benson CA, Chaillon A, Ignacio C, Sepulveda J. PMID: 35277428; PMCID: PMC8919131.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic Health
    21. A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial. Lancet Gastroenterol Hepatol. 2022 04; 7(4):307-317. Solomon SS, Wagner-Cardoso S, Smeaton L, Sowah LA, Wimbish C, Robbins G, Brates I, Scello C, Son A, Avihingsanon A, Linas B, Anthony D, Nunes EP, Kliemann DA, Supparatpinyo K, Kityo C, Tebas P, Bennet JA, Santana-Bagur J, Benson CA, Van Schalkwyk M, Cheinquer N, Naggie S, Wyles D, Sulkowski M. PMID: 35026142; PMCID: PMC8920770.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsCTClinical Trials
    22. Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2021 10 05; 73(7):e2278-e2284. Pettit AC, Stout JE, Belknap R, Benson CA, Séraphin MN, Lauzardo M, Horne DJ, Garfein RS, Maruri F, Ho CS, Tuberculosis Epidemiologic Studies Consortium (TBESC). PMID: 32761083; PMCID: PMC8678585.
      View in: PubMed   Mentions: 5     Fields:    
    23. Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection. Clin Infect Dis. 2021 08 16; 73(4):706-715. Kendall MA, Lalloo U, Fletcher CV, Wu X, Podany AT, Cardoso SW, Ive P, Benson CA. PMID: 34398956; PMCID: PMC8366816.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    24. Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV. J Acquir Immune Defic Syndr. 2021 08 15; 87(5):e234-e236. Gay CL, Bosch RJ, McKhann A, Moseley KF, Wimbish CL, Hendrickx SM, Messer M, Furlong M, Campbell DM, Jennings C, Benson C, Overton ET, Macatangay BJC, Kuritzkes DR, Miller E, Tressler R, Eron JJ, Hardy WD, A5370 Team. PMID: 33929394; PMCID: PMC8263135.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    25. Virtual Recruitment Is Here to Stay: A Survey of ID Fellowship Program Directors and Matched Applicants Regarding Their 2020 Virtual Recruitment Experiences. Open Forum Infect Dis. 2021 Aug; 8(8):ofab383. Rockney D, Benson CA, Blackburn BG, Chirch LM, Konold VJL, Luther VP, Razonable RR, Tackett S, Melia MT. PMID: 34395715; PMCID: PMC8360240.
      View in: PubMed   Mentions: 7  
    26. Convalescent Plasma and Coronavirus Disease 2019: Time for Reassessment. Crit Care Med. 2021 07 01; 49(7):1182-1186. Sweeney DA, Benson CA, Kalil AC. PMID: 33870924.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    27. COVID-19-Lessons Learned and Questions Remaining. Clin Infect Dis. 2021 06 15; 72(12):2225-2240. Fang FC, Benson CA, Del Rio C, Edwards KM, Fowler VG, Fredricks DN, Limaye AP, Murray BE, Naggie S, Pappas PG, Patel R, Paterson DL, Pegues DA, Petri WA, Schooley RT. PMID: 33104186; PMCID: PMC7797746.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    28. Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus-1. Clin Infect Dis. 2021 06 01; 72(11):e815-e824. Riddler SA, Para M, Benson CA, Mills A, Ramgopal M, DeJesus E, Brinson C, Cyktor J, Jacobs J, Koontz D, Mellors JW, Laird GM, Wrin T, Patel H, Guo S, Wallin J, Boice J, Zhang L, Humeniuk R, Begley R, German P, Graham H, Geleziunas R, Brainard DM, SenGupta D. PMID: 33043969.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsCTClinical Trials
    29. Neurocysticercosis in Epileptic Children: An Overlooked Condition in Mozambique, Challenges in Diagnosis, Management and Research Priorities. EC Microbiol. 2021 Jul; 17(6):49-56. Noormahomed EV, Nhancupe N, Mufume J, Schooley RT, Foyaca-Sibat H, Benson CA. PMID: 37441580; PMCID: PMC10338043.
      View in: PubMed   Mentions:
    30. Coinfection of HIV-1 with Schistosoma spp. and with Intestinal Parasites in Patients Attending Boane Health Center, Maputo Province, Mozambique. EC Microbiol. 2021; 17(5):3-16. Banze L, Madureira AC, Zacarias BC, Nhacupe N, Mascaro-Lazcano C, Benson CA, Schooley RT, Noormahomed EV. PMID: 36649459; PMCID: PMC9836084.
      View in: PubMed   Mentions: 1  
    31. Design and Implementation of Postgraduate Programs in Health in a Resource-Limited Setting in Mozambique (The Lúrio University). Adv Med Educ Pract. 2021; 12:399-412. Noormahomed EV, Mandane A, Cuambe A, Rodrigues MA, Noormahomed S, Carrilho C, Mocumbi AO, Ali M, Vintuar P, Ismail M, Guilundo C, Bickler S, Benson CA, Ferrão JL, Schooley RT. PMID: 33911914; PMCID: PMC8075734.
      View in: PubMed   Mentions: 7  
    32. Mitochondrial DNA haplogroups and weight gain following switch to integrase strand transfer inhibitor-based antiretroviral therapy. AIDS. 2021 03 01; 35(3):439-445. Erlandson KM, Wu K, Lake JE, Samuels DC, Bares SH, Tassiopoulos K, Koethe JR, Brown TT, Leonard M, Benson CA, Haas DW, Hulgan T, A5001, A5322 Protocol Teams. PMID: 33252493; PMCID: PMC7951953.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    33. Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine. Pharmacogenet Genomics. 2021 01; 31(1):17-27. Haas DW, Podany AT, Bao Y, Swindells S, Chaisson RE, Mwelase N, Supparatpinyo K, Mohapi L, Gupta A, Benson CA, Baker P, Fletcher CV. PMID: 32815870; PMCID: PMC7655626.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    34. Education of Infectious Diseases Fellows During the COVID-19 Pandemic Crisis: Challenges and Opportunities. Open Forum Infect Dis. 2021 Feb; 8(2):ofaa583. Chirch LM, Armstrong WS, Balba GP, Kulkarni PA, Benson CA, Konold V, Luther VP, Nnedu ON, Perloff S, Razonable RR, Stead W, Thompson GR, Melia MT. PMID: 33553468; PMCID: PMC7798664.
      View in: PubMed   Mentions: 4  
    35. The Role of Stress and Genital Immunity in Sexual Trauma and HIV Susceptibility Among Adolescent Girls and Adult Women (The THRIVE Study): Protocol for a Longitudinal Case-Control Study. JMIR Res Protoc. 2020 Dec 07; 9(12):e18190. Stockman JK, Anderson KM, Karris MY, Benson CA, Tsuyuki K, Granger DA, Weber A, Ghosh M. PMID: 32903198; PMCID: PMC7752525.
      View in: PubMed   Mentions: 3  
    36. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2020 10 27; 324(16):1651-1669. Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, Smith DM, Benson CA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA. PMID: 33052386.
      View in: PubMed   Mentions: 163     Fields:    Translation:HumansCellsPHPublic Health
    37. Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States. Open Forum Infect Dis. 2020 Sep; 7(9):ofaa389. Aslam S, Lampley E, Wooten D, Karris M, Benson C, Strathdee S, Schooley RT. PMID: 33005701; PMCID: PMC7519779.
      View in: PubMed   Mentions: 102  
    38. Impact of Latent Tuberculosis Infection on Neurocognitive Functioning and Inflammation in HIV-Infected and Uninfected South Indians. J Acquir Immune Defic Syndr. 2020 08 01; 84(4):430-436. LaVergne S, Umlauf A, McCutchan A, Heaton R, Benson C, Kumarasamy N, Bharti AR. PMID: 32282443; PMCID: PMC7321856.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE. J Infect Dis. 2020 07 09; 222(Suppl 1):S52-S62. Umbleja T, Brown TT, Overton ET, Ribaudo HJ, Schrack JA, Fitch KV, Douglas PS, Grinspoon SK, Henn S, Arduino RC, Rodriguez B, Benson CA, Erlandson KM. PMID: 32645163; PMCID: PMC7347078.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    40. Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial. PLoS Med. 2019 10; 16(10):e1002891. Browne SH, Umlauf A, Tucker AJ, Low J, Moser K, Gonzalez Garcia J, Peloquin CA, Blaschke T, Vaida F, Benson CA. PMID: 31584944; PMCID: PMC6777756.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    41. One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. N Engl J Med. 2019 03 14; 380(11):1001-1011. Swindells S, Ramchandani R, Gupta A, Benson CA, Leon-Cruz J, Mwelase N, Jean Juste MA, Lama JR, Valencia J, Omoz-Oarhe A, Supparatpinyo K, Masheto G, Mohapi L, da Silva Escada RO, Mawlana S, Banda P, Severe P, Hakim J, Kanyama C, Langat D, Moran L, Andersen J, Fletcher CV, Nuermberger E, Chaisson RE, BRIEF TB/A5279 Study Team. PMID: 30865794; PMCID: PMC6563914.
      View in: PubMed   Mentions: 116     Fields:    Translation:HumansCTClinical Trials
    42. Safety, Tolerability, and Efficacy of Generic Dolutegravir-containing Antiretroviral Therapy Regimens Among South Indian Human Immunodeficiency Virus-infected Patients. Clin Infect Dis. 2019 03 05; 68(6):1048-1051. Kumarasamy N, Prabhu S, Chandrasekaran E, Poongulali S, Pradeep A, Chitra D, Balakrishnan R, Benson CA. PMID: 30192925; PMCID: PMC7182123.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    43. No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial. Open Forum Infect Dis. 2019 Mar; 6(3):ofz056. Li JZ, Sax PE, Marconi VC, Fajnzylber J, Berzins B, Nyaku AN, Fichtenbaum CJ, Wilkin T, Benson CA, Koletar SL, Lorenzo-Redondo R, Taiwo BO. PMID: 30895201; PMCID: PMC6419983.
      View in: PubMed   Mentions: 6  
    44. Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. J Acquir Immune Defic Syndr. 2018 12 15; 79(5):e112-e114. Gianella S, Marconi VC, Berzins B, Benson CA, Sax P, Fichtenbaum CJ, Wilkin T, Vargas M, Deng Q, Oliveira MF, Moser C, Taiwo BO. PMID: 30383591; PMCID: PMC6231952.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    45. Erratum for Schooley et al., "Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection". Antimicrob Agents Chemother. 2018 12; 62(12). Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T. PMID: 30478181; PMCID: PMC6256779.
      View in: PubMed   Mentions: 8     Fields:    
    46. Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy. Clin Infect Dis. 2018 11 13; 67(11):1712-1719. Benson CA, Andersen JW, Macatangay BJC, Mailliard RB, Rinaldo CR, Read S, Bozzolo DR, Purdue L, Jennings C, Keefer MC, Glesby M, Tebas P, Russell AF, Martin J, Annunziato P, Popmihajlov Z, Lennox JL. PMID: 29590326; PMCID: PMC6233680.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    47. Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia. EC Microbiol. 2018 Nov; 14(11):736-740. Saldanha V, Saldanha G, Reys RP, Benson CA, Noormahomed EV. PMID: 31681909; PMCID: PMC6824723.
      View in: PubMed   Mentions: 5  
    48. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2018 07 24; 320(4):379-396. Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, Sax PE, Smith DM, Thompson MA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA. PMID: 30043070; PMCID: PMC6415748.
      View in: PubMed   Mentions: 252     Fields:    Translation:Humans
    49. Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial. Clin Infect Dis. 2018 05 17; 66(11):1794-1797. Taiwo BO, Marconi VC, Berzins B, Moser CB, Nyaku AN, Fichtenbaum CJ, Benson CA, Wilkin T, Koletar SL, Colasanti J, Acosta EP, Li JZ, Sax PE. PMID: 29293895; PMCID: PMC5961309.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    50. The Medical Education Partnership Initiative Effect on Increasing Health Professions Education and Research Capacity in Mozambique. Ann Glob Health. 2018 04 30; 84(1):47-57. Noormahomed EV, Mocumbi AO, Ismail M, Carrilho C, Patel S, Nguenha A, Badaro R, Bickler S, Benson CA, Schooley RT. PMID: 30873790; PMCID: PMC6422173.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    51. A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care. Top Antivir Med. 2017 Dec/Jan; 24(4):142-151. Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA. PMID: 28208122; PMCID: PMC5677050.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017 Nov 29; 65(12):2042-2049. Erlandson KM, Kitch D, Wester CW, Kalayjian RC, Overton ET, Castillo-Mancilla J, Koletar SL, Benson CA, Campbell TB, Robertson K, Lok JJ. PMID: 29020174; PMCID: PMC5850423.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    53. Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection. Antimicrob Agents Chemother. 2017 10; 61(10). Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T. PMID: 28807909; PMCID: PMC5610518.
      View in: PubMed   Mentions: 435     Fields:    Translation:HumansCells
    54. The Medical Education Partnership Initiative (MEPI), a collaborative paradigm for institutional and human resources capacity building between high- and low- and middle-income countries: the Mozambique experience. Glob Health Action. 2017; 10(1):1272879. Virgínia Noormahomed E, Carrilho C, Ismail M, Noormahomed S, Nguenha A, Benson CA, Mocumbi AO, Schooley RT. PMID: 28452653; PMCID: PMC5328351.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    55. Early cerebritis resulting in a first-time seizure in an otherwise healthy young man. Infect Dis Clin Pract (Baltim Md). 2016 Nov; 24(6):e66-e68. Jenks JD, Benson CA. PMID: 27840566; PMCID: PMC5102392.
      View in: PubMed   Mentions: 1  
    56. Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus. PLoS One. 2016; 11(9):e0163616. Logan C, Todorof K, Fiorillo SP, Campbell TB, Elder JH, Borok M, Gudza I, Gwanzura L, Ndemera B, Lochhead MJ, Benson CA, Schooley RT. PMID: 27669509; PMCID: PMC5036886.
      View in: PubMed   Mentions: 1     Fields:    
    57. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2016 Jul 12; 316(2):191-210. Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA. PMID: 27404187; PMCID: PMC5012643.
      View in: PubMed   Mentions: 255     Fields:    Translation:HumansCellsPHPublic Health
    58. Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons. AIDS. 2016 06 19; 30(10):1607-15. Sterling TR, Scott NA, Miro JM, Calvet G, La Rosa A, Infante R, Chen MP, Benator DA, Gordin F, Benson CA, Chaisson RE, Villarino ME, Tuberculosis Trials Consortium, the AIDS Clinical Trials Group for the PREVENT TB Trial (TBTC Study . PMID: 27243774; PMCID: PMC4899978.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    59. A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries. BMC Infect Dis. 2016 06 10; 16:269. Godfrey C, Tauscher G, Hunsberger S, Austin M, Scott L, Schouten JT, Luetkemeyer AF, Benson C, Coombs R, Swindells S, HIV Network Coordinating (HANC) TB Diagnostic Laboratory Working Division of AIDS, National Institut. PMID: 27287374; PMCID: PMC4901412.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    60. Linezolid for Treating Tuberculosis: A Delicate Balancing Act. EBioMedicine. 2015 Nov; 2(11):1568-9. Maartens G, Benson CA. PMID: 26870767; PMCID: PMC4740312.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    61. Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy. Sci Rep. 2015 Aug 24; 5:13179. Massanella M, Gianella S, Schrier R, Dan JM, Pérez-Santiago J, Oliveira MF, Richman DD, Little SJ, Benson CA, Daar ES, Dube MP, Haubrich RH, Smith DM, Morris SR. PMID: 26299251; PMCID: PMC4547398.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    62. Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy. AIDS. 2015 Jun 19; 29(10):1217-25. Labo N, Miley W, Benson CA, Campbell TB, Whitby D. PMID: 26035321; PMCID: PMC6680245.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    63. Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention. Clin Infect Dis. 2015 Oct 15; 61(8):1322-7. Podany AT, Bao Y, Swindells S, Chaisson RE, Andersen JW, Mwelase T, Supparatpinyo K, Mohapi L, Gupta A, Benson CA, Kim P, Fletcher CV, AIDS Clinical Trials Group A5279 Study Team. PMID: 26082504; PMCID: PMC4583578.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCellsCTClinical Trials
    64. Near patient CD4 count in a hospitalized HIV patient population. Cytometry B Clin Cytom. 2017 11; 92(6):451-455. Givens M, Weaver A, Bickman S, Logan C, Noormahomed EV, Patel S, Schooley RT, Benson CA, Lochhead MJ. PMID: 25917935; PMCID: PMC5595587.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    65. Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers. Antimicrob Agents Chemother. 2015; 59(6):3399-405. Dooley KE, Savic RM, Park JG, Cramer Y, Hafner R, Hogg E, Janik J, Marzinke MA, Patterson K, Benson CA, Hovind L, Dorman SE, Haas DW, ACTG A5311 Study Team. PMID: 25824215; PMCID: PMC4432148.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    66. Leishmaniasis as a Manifestation of Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV-Infected Patients: A Literature Review. J Int Assoc Provid AIDS Care. 2015 Sep-Oct; 14(5):402-7. Badaró R, Gonçalves LO, Gois LL, Maia ZP, Benson C, Grassi MF. PMID: 25331225; PMCID: PMC5004440.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    67. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Ann Intern Med. 2014 Oct 07; 161(7):461-71. Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na LH, Godfrey C, Kuritzkes DR, Sagar M, Brown TT, Cohn SE, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, Haas DW, Patterson KB, Benson CA, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS, ACTG A5257 Team. PMID: 25285539; PMCID: PMC4412467.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCellsCTClinical Trials
    68. A cross-sectional serological study of cysticercosis, schistosomiasis, toxocariasis and echinococcosis in HIV-1 infected people in Beira, Mozambique. PLoS Negl Trop Dis. 2014 Sep; 8(9):e3121. Noormahomed EV, Nhacupe N, Mascaró-Lazcano C, Mauaie MN, Buene T, Funzamo CA, Benson CA. PMID: 25188395; PMCID: PMC4154675.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    69. Innovative strategies for transforming internal medicine residency training in resource-limited settings: the Mozambique experience. Acad Med. 2014 Aug; 89(8 Suppl):S78-82. Mocumbi AO, Carrilho C, Aronoff-Spencer E, Funzamo C, Patel S, Preziosi M, Lederer P, Tilghman W, Benson CA, Badaró R, Nguenha A, Schooley RT, Noormahomed EV. PMID: 25072585; PMCID: PMC4116633.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    70. A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy. J Acquir Immune Defic Syndr. 2014 Aug 01; 66(4):399-406. Jacobson JM, Wang H, Bordi R, Zheng L, Gross BH, Landay AL, Spritzler J, Routy JP, Benson C, Aberg J, Tebas P, Haas DW, Tiu J, Coughlin K, Purdue L, Sekaly RP, AIDS Clinical Trials Group (ACTG) A5212 Protocol Team. PMID: 24815851; PMCID: PMC4216663.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    71. HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel. JAMA. 2014 Jul 23-30; 312(4):390-409. Marrazzo JM, del Rio C, Holtgrave DR, Cohen MS, Kalichman SC, Mayer KH, Montaner JS, Wheeler DP, Grant RM, Grinsztejn B, Kumarasamy N, Shoptaw S, Walensky RP, Dabis F, Sugarman J, Benson CA, International Antiviral Society-USA Panel. PMID: 25038358; PMCID: PMC6309682.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    72. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. JAMA. 2014 Jul 23-30; 312(4):410-25. Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA, International Antiviral Society-USA Panel. PMID: 25038359.
      View in: PubMed   Mentions: 229     Fields:    Translation:Humans
    73. Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens. Clin Infect Dis. 2014 Sep 15; 59(6):888-96. Zheng Y, Hughes MD, Lockman S, Benson CA, Hosseinipour MC, Campbell TB, Gulick RM, Daar ES, Sax PE, Riddler SA, Haubrich R, Salata RA, Currier JS. PMID: 24842909; PMCID: PMC4155445.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    74. Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS. J Acquir Immune Defic Syndr. 2014 May 01; 66(1):25-32. Weinberg A, Bosch R, Bennett K, Tovar-Salazar A, Benson CA, Collier AC, Zolopa A, Gulick RM, Wohl D, Polsky B, Erice A, Jacobson MA. PMID: 24378728; PMCID: PMC3981937.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    75. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs. J Acquir Immune Defic Syndr. 2014 Apr 01; 65(4):423-8. Luetkemeyer AF, Kendall MA, Nyirenda M, Wu X, Ive P, Benson CA, Andersen JW, Swindells S, Sanne IM, Havlir DV, Kumwenda J, Adult AIDS Clinical Trials Group A5221 Study Team. PMID: 24226057; PMCID: PMC3943693.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    76. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014 May; 58(9):1308-11. Masur H, Brooks JT, Benson CA, Holmes KK, Pau AK, Kaplan JE, National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association of the Infectious Diseases Society of America. PMID: 24585567; PMCID: PMC3982842.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    77. Strengthening research capacity through the medical education partnership initiative: the Mozambique experience. Hum Resour Health. 2013 Dec 05; 11:62. Noormahomed EV, Mocumbi AO, Preziosi M, Damasceno A, Bickler S, Smith DM, Funzamo C, Aronoff-Spencer E, Badaró R, Mabila F, Bila D, Nguenha A, Do Rosário V, Benson CA, Schooley RT, Patel S, Ferrão LJ, Carrilho C. PMID: 24304706; PMCID: PMC3895849.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    78. The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit. PLoS One. 2013; 8(11):e78676. Wohl DA, Kendall MA, Feinberg J, Alston-Smith B, Owens S, Chafey S, Marco M, Maxwell S, Benson C, Keiser P, van der Horst C, Jacobson MA, A5030 Study Team. PMID: 24260125; PMCID: PMC3829816.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    79. TB-IRIS after initiation of antiretroviral therapy is associated with expansion of preexistent Th1 responses against Mycobacterium tuberculosis antigens. J Acquir Immune Defic Syndr. 2013 Nov 01; 64(3):241-8. Vignesh R, Kumarasamy N, Lim A, Solomon S, Murugavel KG, Balakrishnan P, Solomon SS, Mayer KH, Swathirajan CR, Chandrasekaran E, Pradeep A, Poongulali S, Benson CA, French MA. PMID: 23774879; PMCID: PMC5592834.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    80. The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy. AIDS. 2013 Aug 24; 27(13):2101-10. Lok JJ, Hunt PW, Collier AC, Benson CA, Witt MD, Luque AE, Deeks SG, Bosch RJ. PMID: 24326304; PMCID: PMC3933027.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    81. Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study. Clin Infect Dis. 2013 Aug; 57(4):586-93. Luetkemeyer AF, Rosenkranz SL, Lu D, Marzan F, Ive P, Hogg E, Swindells S, Benson CA, Grinsztejn B, Sanne IM, Havlir DV, Aweeka F, Adult AIDS Clinical Trials Group A5221 Study Team. PMID: 23592830; PMCID: PMC3719885.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    82. Drug-resistant virus has reduced ability to induce immune activation. J Acquir Immune Defic Syndr. 2012 Dec 01; 61(4):e60-3. Wang R, Bosch RJ, Benson CA, Lederman MM. PMID: 23138731; PMCID: PMC3499025.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    83. Performance evaluation of the MBio Diagnostics point-of-care CD4 counter. J Immunol Methods. 2013 Jan 31; 387(1-2):107-13. Logan C, Givens M, Ives JT, Delaney M, Lochhead MJ, Schooley RT, Benson CA. PMID: 23063690; PMCID: PMC3529779.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    84. Clinical outcomes among HIV/tuberculosis-coinfected patients developing immune reconstitution inflammatory syndrome after HAART initiation in South India. J Int Assoc Provid AIDS Care. 2013 Jan-Feb; 12(1):28-31. Kumarasamy N, Venkatesh KK, Vignesh R, Devaleenal B, Poongulali S, Yepthomi T, Flanigan TP, Benson C, Mayer KH. PMID: 23011868; PMCID: PMC5578704.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012 Jul 25; 308(4):387-402. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Günthard HF, Hammer SM, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA. PMID: 22820792.
      View in: PubMed   Mentions: 367     Fields:    Translation:Humans
    86. Association of low level viremia with inflammation and mortality in HIV-infected adults. PLoS One. 2011; 6(11):e26320. Eastburn A, Scherzer R, Zolopa AR, Benson C, Tracy R, Do T, Bacchetti P, Shlipak M, Grunfeld C, Tien PC. PMID: 22073156; PMCID: PMC3206804.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    87. CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap. Am J Respir Crit Care Med. 2011 Oct 15; 184(8):972-9. Nahid P, Saukkonen J, Mac Kenzie WR, Johnson JL, Phillips PP, Andersen J, Bliven-Sizemore E, Belisle JT, Boom WH, Luetkemeyer A, Campbell TB, Eisenach KD, Hafner R, Lennox JL, Makhene M, Swindells S, Villarino ME, Weiner M, Benson C, Burman W, National Institutes of Health, Centers for Disease Control and Prevention. PMID: 21737585; PMCID: PMC3208659.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    88. Rapid multiplexed immunoassay for simultaneous serodiagnosis of HIV-1 and coinfections. J Clin Microbiol. 2011 Oct; 49(10):3584-90. Lochhead MJ, Todorof K, Delaney M, Ives JT, Greef C, Moll K, Rowley K, Vogel K, Myatt C, Zhang XQ, Logan C, Benson C, Reed S, Schooley RT. PMID: 21865431; PMCID: PMC3187301.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    89. Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. Am J Epidemiol. 2011 Sep 15; 174(6):727-35. Abraham AG, Lau B, Deeks S, Moore RD, Zhang J, Eron J, Harrigan R, Gill MJ, Kitahata M, Klein M, Napravnik S, Rachlis A, Rodriguez B, Rourke S, Benson C, Bosch R, Collier A, Gebo K, Goedert J, Hogg R, Horberg M, Jacobson L, Justice A, Kirk G, Martin J, McKaig R, Silverberg M, Sterling T, Thorne J, Willig J, Gange SJ, North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic D. PMID: 21813792; PMCID: PMC3202147.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    90. Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis. Oncology. 2011; 80(1-2):42-9. Krishnan S, Schouten JT, Jacobson DL, Benson CA, Collier AC, Koletar SL, Santana J, Sattler FR, Mitsuyasu R, ACTG-ALLRT Protocol Team. PMID: 21606663; PMCID: PMC3121543.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    91. Extensive geographical mixing of 2009 human H1N1 influenza A virus in a single university community. J Virol. 2011 Jul; 85(14):6923-9. Holmes EC, Ghedin E, Halpin RA, Stockwell TB, Zhang XQ, Fleming R, Davey R, Benson CA, Mehta S, Taplitz R, Liu YT, Brouwer KC, Wentworth DE, Lin X, Schooley RT, INSIGHT FLU002 Study Group. PMID: 21593168; PMCID: PMC3126550.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    92. No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT. Clin Infect Dis. 2011 Apr 01; 52(7):929-40. Ribaudo HJ, Benson CA, Zheng Y, Koletar SL, Collier AC, Lok JJ, Smurzynski M, Bosch RJ, Bastow B, Schouten JT, ACTG A5001/ALLRT Protocol Team. PMID: 21427402; PMCID: PMC3062545.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    93. Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. Ann Intern Med. 2011 Apr 05; 154(7):445-56. Daar ES, Tierney C, Fischl MA, Sax PE, Mollan K, Budhathoki C, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Pappa KA, Woodward WC, Patterson K, Bolivar H, Benson CA, Collier AC, AIDS Clinical Trials Group Study A5202 Team. PMID: 21320923; PMCID: PMC3430716.
      View in: PubMed   Mentions: 137     Fields:    Translation:HumansCells
    94. CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? AIDS Res Ther. 2010 Dec 15; 7:45. Althoff KN, Gebo KA, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Eron JJ, Napravnik S, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Deeks SG, Martin JN, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Goedert JJ, McKaig RG, Thorne J, Rachlis A, Moore RD, Justice AC, North American AIDS Cohort Collaboration on Research and Design. PMID: 21159161; PMCID: PMC3022663.
      View in: PubMed   Mentions: 38     Fields:    
    95. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort. J Acquir Immune Defic Syndr. 2010 Nov; 55(3):316-22. Tien PC, Choi AI, Zolopa AR, Benson C, Tracy R, Scherzer R, Bacchetti P, Shlipak M, Grunfeld C. PMID: 20581689; PMCID: PMC2955817.
      View in: PubMed   Mentions: 154     Fields:    Translation:Humans
    96. Tuberculosis due to Mycobacterium bovis in patients coinfected with human immunodeficiency virus. Clin Infect Dis. 2010 Dec 01; 51(11):1343-6. Park D, Qin H, Jain S, Preziosi M, Minuto JJ, Mathews WC, Moser KS, Benson CA. PMID: 21028986.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    97. Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials study. J Acquir Immune Defic Syndr. 2010 Sep; 55(1):117-27. Smurzynski M, Wu K, Benson CA, Bosch RJ, Collier AC, Koletar SL. PMID: 20622677; PMCID: PMC2927805.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    98. Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection. AIDS. 2010 Jul 31; 24(12):1867-76. Lok JJ, Bosch RJ, Benson CA, Collier AC, Robbins GK, Shafer RW, Hughes MD, ALLRT team. PMID: 20467286; PMCID: PMC3018341.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    99. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010 Jun 01; 50(11):1512-20. Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Justice AC, Gebo KA, Eron JJ, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Calzavara LM, Deeks SG, Martin JN, Rachlis AR, Napravnik S, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Kushel M, Goedert JJ, McKaig RG, Van Rompaey SE, Zhang J, Moore RD. PMID: 20415573; PMCID: PMC2862849.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    100. Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection. J Acquir Immune Defic Syndr. 2010 Feb; 53(2):194-201. May S, Gamst A, Haubrich R, Benson C, Smith DM. PMID: 19770802; PMCID: PMC2915780.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    101. Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis. 2009 Nov 15; 49(10):1582-90. Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Kushel MB, Goedert JJ, McKaig RG, Moore RD. PMID: 19845473; PMCID: PMC2871149.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    102. The use of pooled viral load testing to identify antiretroviral treatment failure. AIDS. 2009 Oct 23; 23(16):2151-8. Smith DM, May SJ, Pérez-Santiago J, Strain MC, Ignacio CC, Haubrich RH, Richman DD, Benson CA, Little SJ. PMID: 19730348; PMCID: PMC2915784.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    103. High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings. Clin Infect Dis. 2009 Jul 15; 49(2):306-9. Kumarasamy N, Madhavan V, Venkatesh KK, Saravanan S, Kantor R, Balakrishnan P, Devaleenal B, Poongulali S, Yepthomi T, Solomon S, Mayer KH, Benson C, Schooley R. PMID: 19522657; PMCID: PMC8559152.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    104. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009 Apr 10; 58(RR-4):1-207; quiz CE1-4. Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H, Centers for Disease Control and Prevention (CDC), National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America. PMID: 19357635.
      View in: PubMed   Mentions: 575     Fields:    Translation:Humans
    105. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009 Apr 30; 360(18):1815-26. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD, NA-ACCORD Investigators. PMID: 19339714; PMCID: PMC2854555.
      View in: PubMed   Mentions: 507     Fields:    Translation:HumansCells
    106. HIV-associated opportunistic infections--going, going, but not gone: the continued need for prevention and treatment guidelines. Clin Infect Dis. 2009 Mar 01; 48(5):609-11. Brooks JT, Kaplan JE, Holmes KK, Benson C, Pau A, Masur H. PMID: 19191648.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    107. AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics. HIV Clin Trials. 2008 Jul-Aug; 9(4):269-82. Smurzynski M, Collier AC, Koletar SL, Bosch RJ, Wu K, Bastow B, Benson CA. PMID: 18753121; PMCID: PMC2704053.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    108. Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy. Clin Vaccine Immunol. 2008 Jun; 15(6):986-94. Wilson CC, Newman MJ, Livingston BD, MaWhinney S, Forster JE, Scott J, Schooley RT, Benson CA. PMID: 18400976; PMCID: PMC2446619.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsCTClinical Trials
    109. Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186. J Acquir Immune Defic Syndr. 2008 Apr 01; 47(4):459-66. Gerber JG, Kitch DW, Fichtenbaum CJ, Zackin RA, Charles S, Hogg E, Acosta EP, Connick E, Wohl D, Kojic EM, Benson CA, Aberg JA. PMID: 17971707; PMCID: PMC2788607.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    110. Cross-sectional study of endothelial function in HIV-infected patients in Brazil. AIDS Res Hum Retroviruses. 2008 Jan; 24(1):27-33. Andrade AC, Ladeia AM, Netto EM, Mascarenhas A, Cotter B, Benson CA, Badaró R. PMID: 18275345.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    111. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS. 2007 Nov 30; 21(18):2473-82. McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA. PMID: 18025884.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    112. Immunophenotypic alterations in acute and early HIV infection. Clin Immunol. 2007 Dec; 125(3):299-308. Al-Harthi L, MaWhinney S, Connick E, Schooley RT, Forster JE, Benson C, Thompson M, Judson F, Palella F, Landay A. PMID: 17916441; PMCID: PMC2702986.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    113. Prevalence and factors associated with dry skin in HIV infection: the FRAM study. AIDS. 2007 Oct 01; 21(15):2051-7. Lee D, Benson CA, Lewis CE, Grunfeld C, Scherzer R. PMID: 17885295; PMCID: PMC3166536.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    114. Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapy. J Acquir Immune Defic Syndr. 2007 Mar 01; 44(3):268-77. Bosch RJ, Bennett K, Collier AC, Zackin R, Benson CA. PMID: 17146370.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    115. Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment. Clin Infect Dis. 2007 Mar 01; 44(5):749-54. Landay A, da Silva BA, King MS, Albrecht M, Benson C, Eron J, Glesby M, Gulick R, Hicks C, Kessler H, Murphy R, Thompson M, White AC, Wolfe P, McMillan FI, Hanna GJ. PMID: 17278071.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    116. Whole-blood interleukin-18 level during early HIV-1 infection is associated with reduced CXCR4 coreceptor expression and interferon- gamma levels. J Infect Dis. 2007 Mar 01; 195(5):734-8. Sailer CA, Pott GB, Dinarello CA, Whinney SM, Forster JE, Larson-Duran JK, Landay A, Al-Harthi L, Schooley RT, Benson CA, Judson FN, Thompson M, Palella FJ, Shapiro L. PMID: 17262717.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    117. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. J Clin Endocrinol Metab. 2007 Feb; 92(2):563-70. Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M, ACTG 313 Study Team. PMID: 17090640.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    118. A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086. J Infect Dis. 2006 Nov 01; 194(9):1309-18. Benson CA, Vaida F, Havlir DV, Downey GF, Lederman MM, Gulick RM, Glesby MJ, Wantman M, Bixby CJ, Rinehart AR, Snyder S, Wang R, Patel S, Mellors JW, ACTG A5086 Study Team. PMID: 17041858.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    119. Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study. J Infect Dis. 2006 Oct 15; 194(8):1098-107. Haas DW, Geraghty DE, Andersen J, Mar J, Motsinger AA, D'Aquila RT, Unutmaz D, Benson CA, Ritchie MD, Landay A, AIDS Clinical Trials Group. PMID: 16991084.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    120. Structured treatment interruptions--new findings. Top HIV Med. 2006 Aug-Sep; 14(3):107-11. Benson CA. PMID: 16946455.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    121. The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics. Am J Epidemiol. 2006 May 01; 163(9):860-9. Tien PC, Benson C, Zolopa AR, Sidney S, Osmond D, Grunfeld C. PMID: 16524955; PMCID: PMC3170407.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    122. Clinical validation of the NeuroScreen. J Neurovirol. 2005 Dec; 11(6):503-11. Ellis RJ, Evans SR, Clifford DB, Moo LR, McArthur JC, Collier AC, Benson C, Bosch R, Simpson D, Yiannoutsos CT, Yang Y, Robertson K, Neurological AIDS Research Consortium, AIDS Clinical Trials Group Study Teams A5001 and A362. PMID: 16338744.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    123. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep. 2004 Dec 17; 53(RR-15):1-112. Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK, CDC, National Institutes of Health, Infectious Diseases Society of America. PMID: 15841069.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    124. A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV. AIDS. 2004 Nov 19; 18(17):2269-76. Benson CA, van der Horst C, Lamarca A, Haas DW, McDonald CK, Steinhart CR, Rublein J, Quinn JB, Mondou E, Rousseau F, FTC-303/350 Writing Group. PMID: 15577539.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsCTClinical Trials
    125. Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study. AIDS. 2004 Mar 26; 18(5):775-9. Hicks C, King MS, Gulick RM, White AC, Eron JJ, Kessler HA, Benson C, King KR, Murphy RL, Brun SC. PMID: 15075512.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsCTClinical Trials
    126. MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group study. J Acquir Immune Defic Syndr. 2003 Nov 01; 34(3):295-8. Haas DW, Wu H, Li H, Bosch RJ, Lederman MM, Kuritzkes D, Landay A, Connick E, Benson C, Wilkinson GR, Kessler H, Kim RB. PMID: 14600574.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsCTClinical Trials
    127. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. Clin Infect Dis. 2003 Nov 01; 37(9):1234-43. Benson CA, Williams PL, Currier JS, Holland F, Mahon LF, MacGregor RR, Inderlied CB, Flexner C, Neidig J, Chaisson R, Notario GF, Hafner R, AIDS Clinical Trials Group 223 Protocol Team. PMID: 14557969.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCellsCTClinical Trials
    128. Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin. Clin Pharmacol Ther. 2003 Mar; 73(3):159-69. Hamzeh FM, Benson C, Gerber J, Currier J, McCrea J, Deutsch P, Ruan P, Wu H, Lee J, Flexner C, AIDS Clinical Trials Group 365 Study Team. PMID: 12621381.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    129. Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients. J Infect Dis. 2002 Mar 01; 185(5):599-607. Benson CA, Deeks SG, Brun SC, Gulick RM, Eron JJ, Kessler HA, Murphy RL, Hicks C, King M, Wheeler D, Feinberg J, Stryker R, Sax PE, Riddler S, Thompson M, Real K, Hsu A, Kempf D, Japour AJ, Sun E. PMID: 11865416.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    Constance's Networks
    Concepts (443)
    Derived automatically from this person's publications.
    _
    Co-Authors (74)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _